Table.
Baseline characteristics
| Placebo (n=24) | Two doses of 5 μg vaccine (n=24) | Two doses of 15 μg vaccine (n=24) | Two doses of 45 μg vaccine (n=24) | One dose of 45 μg vaccine (n=24) | ||
|---|---|---|---|---|---|---|
| Age, years | 32·6 (11·0) | 34·1 (11·9) | 31·0 (10·6) | 32·6 (10·2) | 32·0 (8·7) | |
| Sex | ||||||
| Female | 13 (54%) | 13 (54%) | 13 (54%) | 11 (46%) | 5 (21%) | |
| Male | 11 (46%) | 11 (46%) | 11 (46%) | 13 (54%) | 19 (79%) | |
| Body-mass index, kg/m2 | 24·3 (3·8) | 25·0 (4·1) | 25·6 (4·6) | 25·0 (3·7) | 25·8 (4·0) | |
| Ethnicity | ||||||
| White | 21 (88%) | 21 (88%) | 19 (79%) | 16 (67%) | 17 (71%) | |
| Asian | 3 (13%) | 3 (13%) | 4 (17%) | 8 (33%) | 6 (25%) | |
| Other* | 0 | 0 | 1 (4%) | 0 | 1 (4%) | |
Data are mean (SD) or n (%).
*
Other refers to people of mixed heritage and Indigenous Australians.